ALNY- Alnylam Pharmaceuticals, Inc.

Name: Alnylam Pharmaceuticals, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Alnylam Pharmaceuticals, Inc. (ALNY) has 17 insiders with recent SEC Form 4 filings, including 0 buys and 173 sells. ALNY is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Greenstreet Yvonne	79.1K	$23.41M	-
CFO	Poulton Jeffrey V.	58.4K	$17.28M	-
VP	Tanguler Tolga	30.2K	$8.95M	-
VP	Garg Pushkal	23.7K	$7.01M	-
VP	Fitzgerald Kevin Joseph	21.4K	$6.33M	-

Activity

Buys and sells only

Transactions

10 filings

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Jan 13, 2026	Fitzgerald Kevin Joseph	CSO &EVP, Head Of Research	Sell	3,800	$367.37	$1,395,992.00	-0.6%	-12.9%	-
Jan 12, 2026	Garg Pushkal50	EVP Chief R&D	Sell	1,510	$362.87	$547,928.97	-0.3%	-13.2%	-
Jan 12, 2026	Greenstreet Yvonne46	Chief Executive Officer	Sell	9,577	$362.86	$3,475,156.51	-0.6%	-13.2%	-
Jan 12, 2026	Poulton Jeffrey V.45	EVP, Chief Financial Officer	Sell	2,780	$362.87	$1,008,765.87	-0.2%	-13.2%	-
Jan 12, 2026	Tanguler Tolga57	EVP, Chief Commercial Officer	Sell	1,510	$362.87	$547,927.38	-0.2%	-13.2%	-
Nov 17, 2025	Fitzgerald Kevin Joseph	CSO &EVP, Head Of Research	Sale+OE	12,128	$452.18	$5,483,989.61	-4.5%	-27.8%	-
Nov 13, 2025	Greenstreet Yvonne46	Chief Executive Officer	Sale+OE	25,650	$452.75	$11,613,003.42	-1.8%	-29.0%	-
Oct 3, 2025	Garg Pushkal50	EVP Chief R&D	Sell	5,959	$451.76	$2,692,061.89	-1.5%	-12.3%	-
Oct 2, 2025	Tanguler Tolga57	EVP, Chief Commercial Officer	Sell	1,199	$452.50	$542,549.41	-0.5%	-13.7%	-
Oct 2, 2025	Fitzgerald Kevin Joseph	CSO &EVP, Head Of Research	Sell	661	$454.98	$300,740.31	-0.5%	-13.7%	-

Page 1Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC